Heat sensitivity in multiple sclerosis is well known, but doctors say cold weather can also worsen symptoms. From nerve ...
AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to ...
MedPage Today on MSN
FCRN blockers vie to become first approved drug for Sjogren's disease
The first FDA-approved treatment option for Sjögren's disease might be on the horizon, as neonatal Fc receptor (FcRn) blockers show promise in early data. B-cell activation in Sjögren's disease ...
Everyday Health on MSN
When MS and RA co-occur: How to cope
MS and RA can occur together and share some symptoms. Managing both conditions works best when you coordinate care and treatment with a neurologist and a rheumatologist.
Sanofi’s PERSEUS phase 3 study of tolebrutinib in primary progressive multiple sclerosis fails to meet primary endpoint: Paris Tuesday, December 16, 2025, 11:00 Hrs [IST] Sanofi ...
Hyderabad: Trigeminal neuralgia is a neurological condition marked by sudden, severe facial pain that can interfere with ...
Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis. PERSEUS phase 3 study in primary progressive multiple sclerosis did not meet its primary endpoint ...
An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...
Tiffany Fransen's lifelong clumsiness turned out to be a rare neurodegenerative disease. Friedreich’s ataxia leads to muscle ...
A deadly deer disease is quickly spreading across areas of Middle Tennessee, inching its way closer to Nashville and Davidson County.
The CEMIP enzyme inhibits the growth of oligodendrocytes and may serve as a therapeutic target to boost myelin repair in MS, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback